Clinical Trial Update: A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of first-line ovarian cancer treatment using Avastin (bevacizumab) with carboplatin and weekly paclitaxel; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-02-24